Results 51 to 60 of about 8,024,802 (308)

Feasibility of ablative stereotactic body radiation therapy of pancreas cancer patients on a 1.5 Tesla magnetic resonance-linac system using abdominal compression

open access: yesPhysics and Imaging in Radiation Oncology, 2021
Background and Purpose Stereotactic body radiation therapy delivered using MR-guided radiotherapy (MRgRT) and automatic breathold gating has shown to improve overall survival for locally advanced pancreatic cancer (LAPC) patients.
N. Tyagi   +8 more
semanticscholar   +1 more source

Local control and survival after stereotactic body radiation therapy of early-stage lung cancer patients in Slovenia

open access: yesRadiology and Oncology, 2023
Stereotactic body radiation therapy (SBRT) precisely and non-invasively delivers ablative radiation dose to tumors in early-stage lung cancer patients who are not candidates for surgery or refuse it.
Stanic Karmen   +3 more
doaj   +1 more source

Multi-institutional dose-segmented dosiomic analysis for predicting radiation pneumonitis after lung stereotactic body radiation therapy.

open access: yesMedical Physics (Lancaster), 2021
PURPOSE To predict radiation pneumonitis (RP) grade 2 or worse after lung stereotactic body radiation therapy (SBRT) using dose-based radiomic (dosiomic) features.
T. Adachi   +11 more
semanticscholar   +1 more source

Radiobiological mechanisms of stereotactic body radiation therapy and stereotactic radiation surgery [PDF]

open access: yesRadiation Oncology Journal, 2015
Despite the increasing use of stereotactic body radiation therapy (SBRT) and stereotactic radiation surgery (SRS) in recent years, the biological base of these high-dose hypo-fractionated radiotherapy modalities has been elusive. Given that most human tumors contain radioresistant hypoxic tumor cells, the radiobiological principles for the conventional
Kim, Mi-Sook   +7 more
openaire   +2 more sources

Immunomodulatory Effects of Stereotactic Body Radiation Therapy: Preclinical Insights and Clinical Opportunities

open access: yes, 2021
Preclinical evidence suggests that stereotactic body radiation therapy (SBRT) is immunomodulatory. Given the potential to augment local and systemic antitumor responses, there is significant interest in the combination of SBRT with various ...
Kong, FMS   +25 more
core   +1 more source

A phase II trial proposal of total neoadjuvant treatment with primary chemotherapy, stereotactic body radiation therapy, and intraoperative radiation therapy in borderline resectable pancreatic adenocarcinoma [PDF]

open access: yes, 2021
The current management guidelines recommend that patients with borderline resectable pancreatic adenocarcinoma (BRPC) should initially receive neoadjuvant chemotherapy.
Mazzarotto, Renzo   +39 more
core   +1 more source

CyberKnife Stereotactic Body Radiation Therapy as an Effective Treatment for Hepatocellular Carcinoma Patients With Decompensated Cirrhosis

open access: yesFrontiers in Oncology, 2020
Purpose: The aim of our study was to evaluate the curative effect and safety of CyberKnife stereotactic body radiation therapy in treating decompensated cirrhosis hepatocellular carcinoma (HCC) patients.Methods: From March 2011 to December 2015, 32 HCC ...
Jing Sun   +9 more
doaj   +1 more source

Lung Stereotactic Body Radiation Therapy (SBRT) dose gradient and PTV volume: a retrospective multi-center analysis

open access: yesRadiation Oncology, 2019
Background The treatment of lung lesions with stereotactic body radiation therapy calls for highly conformal dose, which is evaluated by a number of metrics. Lung stereotactic body radiation therapy clinical trials constrain a plans gradient index.
David Hoffman   +4 more
doaj   +1 more source

Rationale for Involved Field Stereotactic Body Radiation Therapy-Enhanced Intermittent Androgen Deprivation Therapy in Hormone-Sensitive Nodal Oligo-Recurrent Prostate Cancer Following Prostate Stereotactic Body Radiation Therapy

open access: yesFrontiers in Oncology, 2021
Lymph node recurrent prostate cancer is a common clinical scenario that is likely to increase significantly with the widespread adoption of novel positron emission tomography (PET) agents.
Michael Carrasquilla   +17 more
doaj   +1 more source

High local failure rates despite high margin‐negative resection rates in a cohort of borderline resectable and locally advanced pancreatic cancer patients treated with stereotactic body radiation therapy following multi‐agent chemotherapy

open access: yesCancer Medicine, 2022
Stereotactic body radiation therapy (SBRT) for patients with borderline resectable and locally advanced pancreatic adenocarcinoma (BRPC/LAPC) remains controversial.
C. Hill   +18 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy